Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.58 USD | +1.57% | +18.35% | +4.88% |
Mar. 27 | HC Wainwright Adjusts BioAtla's Price Target to $7 From $10, Maintains Buy Rating | MT |
Mar. 26 | Transcript : BioAtla, Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 124M |
---|---|---|---|---|---|
Net income 2024 * | -107M | Net income 2025 * | -127M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.34
x | P/E ratio 2025 * |
-1.46
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.15% |
Latest transcript on BioAtla, Inc.
1 day | +1.57% | ||
1 week | +18.35% | ||
Current month | -25.00% | ||
1 month | -25.00% | ||
3 months | +18.89% | ||
6 months | +103.15% | ||
Current year | +4.88% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Short
CEO | Chief Executive Officer | 66 | 07-02-28 |
Founder | 59 | 07-02-28 | |
Richard Waldron
DFI | Director of Finance/CFO | 70 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 20-11-30 |
Jay Short
CEO | Chief Executive Officer | 66 | 07-02-28 |
Director/Board Member | 76 | 15-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 2.58 | +1.57% | 478,492 |
24-04-26 | 2.54 | +12.89% | 295,270 |
24-04-25 | 2.25 | -4.26% | 398,980 |
24-04-24 | 2.35 | +4.91% | 395,798 |
24-04-23 | 2.24 | +2.75% | 672,657 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.88% | 124M | |
+1.77% | 42.86B | |
+46.00% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- BCAB Stock